Satellos Bioscience Inc.
MSCL
Rank in Stocks
#17827
Satellos Bioscience Inc., a biotechnology firm established in 2018 and... Satellos Bioscience Inc., a biotechnology firm established in 2018 and headquartered in Toronto, Canada, specializes in developing regenerative therapies for degenerative muscle diseases. The company primarily operates in Canada and Australia, utilizing its proprietary MyoReGenX platform – an automated microscopy system engineered to replicate the muscle stem cell environment outside the body. A key focus for Satellos is the discovery and development of a small molecule drug specifically aimed at treating Duchenne muscular dystrophy.
Share Price
$10.22
Last synced: 2026-07-31
Market Cap
$212.97M
Change (1 day)
4.58%
Change (1 year)
2,278.10%
Country
CA
Trade Satellos Bioscience Inc. (MSCL)
Category
Healthcare
Stock split history for Satellos Bioscience Inc. (MSCL)
Satellos Bioscience Inc. stock (symbol: MSCL) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One MSCL share bought prior to Oct 20, 2026 would equal to 0 MSCL shares today.
The most recent stock split occurred on Oct 20, 2026.
One MSCL share bought prior to Oct 20, 2026 would equal to 0 MSCL shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
